Natalie Mona Edner (Natalie M Edner)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 10

Top Topics

Dendritic Cells

Peripheral Blood

Top Venues

Nature reviews. Drug discovery

Nature communications

Immunotherapy advances

The Journal of experimental medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Chun Jing Wang, Lina Petersone, Natalie Mona Edner, Frank Heuts, Vitalijs Ovcinnikovs, Elisavet Ntavli, Alexandros Kogimtzis, Astrid Fabri, Yassin Elfaki, Luke P Houghton, Ralf J Hosse, David A Schubert, Andreas P Frei, Ellen M Ross, Lucy Sarah Kate Walker
Author Correction: Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity. Nature communications 14 (1) (2023)
Lina Petersone, Chun Jing Wang, Natalie Mona Edner, Astrid Fabri, Spyridoula-Angeliki Nikou, Claudia Hinze, Ellen M Ross, Elisavet Ntavli, Yassin Elfaki, Frank Heuts, Vitalijs Ovcinnikovs, Andrea Rueda Gonzalez, Luke P Houghton, Hannah M Li, Yang Zhang, Kai-Michael Toellner, Lucy Sarah Kate Walker
IL-21 shapes germinal center polarization via light zone B cell selection and cyclin D3 upregulation. The Journal of experimental medicine 220 (10) (2023)
Natalie Mona Edner, Elisavet Ntavli, Lina Petersone, Chun Jing Wang, Astrid Fabri, Alexandros Kogimtzis, Vitalijs Ovcinnikovs, Ellen M Ross, Frank Heuts, Yassin Elfaki, Luke P Houghton, Toby Talbot, Amna Sheri, Alexandra Pender, David Chao, Lucy Sarah Kate Walker
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood. Immunotherapy advances 3 (1) (2023)
Natalie Mona Edner, Elisavet Ntavli, Lina Petersone, Chun Jing Wang, Astrid Fabri, Alexandros Kogimtzis, Vitalijs Ovcinnikovs, Ellen M Ross, Frank Heuts, Yassin Elfaki, Luke P Houghton, Toby Talbot, Amna Sheri, Alexandra Pender, David Chao, Lucy Sarah Kate Walker
Stratification of PD-1 blockade response in melanoma using pre- and post-treatment immunophenotyping of peripheral blood. Immunotherapy advances 3 (1) (2023)
Thomas Andrew Fox, Benjamin Christopher Houghton, Lina Petersone, Erin Waters, Natalie Mona Edner, Alex McKenna, Olivier Preham, Claudia Hinze, Cayman Williams, Adriana Silva de Albuquerque, Alan Kennedy, Anne Maria Pesenacker, Pietro Genovese, Lucy Sarah Kate Walker, Siobhan Oisin Burns, David Michael Sansom, Claire Booth, Emma Catherine Morris
Therapeutic gene editing of T cells to correct CTLA-4 insufficiency. Science translational medicine 14 (668) (2022)
Chun Jing Wang, Lina Petersone, Natalie Mona Edner, Frank Heuts, Vitalijs Ovcinnikovs, Elisavet Ntavli, Alexandros Kogimtzis, Astrid Fabri, Yassin Elfaki, Luke P Houghton, Ralf J Hosse, David A Schubert, Andreas P Frei, Ellen M Ross, Lucy Sarah Kate Walker
Costimulation blockade in combination with IL-2 permits regulatory T cell sparing immunomodulation that inhibits autoimmunity. Nature communications 13 (1) (2022)
Natalie Mona Edner, Frank Heuts, Niclas Thomas, Chun Jing Wang, Lina Petersone, Rupert Kenefeck, Alexandros Kogimtzis, Vitalijs Ovcinnikovs, Ellen M Ross, Elisavet Ntavli, Yassin Elfaki, Martin Eichmann, Roman Baptista, Philip Ambery, Lutz Jermutus, Mark Peakman, Miranda Rosenthal, Lucy Sarah Kate Walker
Follicular helper T cell profiles predict response to costimulation blockade in type 1 diabetes. Nature immunology 21 (10) (2020)
Natalie Mona Edner, Gianluca Carlesso, James S Rush, Lucy Sarah Kate Walker
Targeting co-stimulatory molecules in autoimmune disease. Nature reviews. Drug discovery 19 (12) (2020)
Natalie Mona Edner, Gianluca Carlesso, James S Rush, Lucy Sarah Kate Walker
Publisher Correction: Targeting co-stimulatory molecules in autoimmune disease. Nature reviews. Drug discovery (2020)
Vitalijs Ovcinnikovs, Ellen M Ross, Lina Petersone, Natalie Mona Edner, Frank Heuts, Elisavet Ntavli, Alexandros Kogimtzis, Alan Kennedy, Chun Jing Wang, Clare L Bennett, David M Sansom, Lucy Sarah Kate Walker
CTLA-4-mediated transendocytosis of costimulatory molecules primarily targets migratory dendritic cells. Science immunology 4 (35) (2020)